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One approach to identify epitopes that could be used in the design of vaccines to control several arthropod-borne diseases
simultaneously is to look for common structural features in the secretome of the pathogens that cause them. Using a novel
bioinformatics technique, cysteine-abundance and distribution analysis, we found that many diﬀerent proteins secreted by several
arthropod-bornepathogens,includingPlasmodiumfalciparum,Borreliaburgdorferi,andeightspeciesofProteobacteria,aredevoid
ofcysteineresidues.Theidentiﬁcationofthreecysteine-abundanceanddistributionpatternsinseveralfamiliesofproteinssecreted
bypathogenicandnonpathogenicProteobacteria,andnotfoundwhentheaminoacidanalyzedwastryptophan,providesevidence
offorcesrestrictingthecontentofcysteineresiduesinmicrobialproteinsduringevolution.Wediscusstheseﬁndingsinthecontext
of protein structure and function, antigenicity and immunogenicity, and host-parasite relationships.
1.Introduction
Microbial pathogens transmitted by hematophagous arthro-
podsareresponsibleforsomeofthemostdevastatinghuman
diseasesandthedesignofvaccinestocontrolthemrepresents
one of the main collective eﬀorts in global health. These
arthropod-borne diseases (ABDs) are caused by hundreds of
species of viruses, bacteria, protozoa, and metazoan parasites
and are transmitted by hematophagous mosquitoes, ﬂies,
ﬂeas, lice, biting midges, kissing bugs, ticks, and mites [1].
Some ABDs are emerging, reemerging, or out-of-control as
a result of high mobility of vertebrate and invertebrate hosts,
environmentaldegradation,andglobalwarming[2].Further
complicating the bleak scenario that ABDs represent, several
of the pathogens that cause them could potentially be used
as weapons [3–5]. Vaccination remains one of the most cost-
eﬀective interventions in public health but only a handful of
eﬀective vaccines are available for the control of ABDs [6, 7].
Central to attempts to control infectious diseases through
use of vaccines is the idea that species-speciﬁc immunity
is the best way to induce safe and eﬀective protection. In
light of the monumental task of the development of vaccines
directedtoeachspeciesofarthropod-borne pathogenand/or
their vectors, it is necessary to revisit the idea of cross-
reactive immunity as a potential venue to protect humans
and animals against several ABDs simultaneously. Thanks to
advances in synthetic peptide libraries and phage expression
libraries, evidence is accumulating that supports the concept
of functional poly-speciﬁcity of antibodies [8, 9]. Such poly-
speciﬁcity could be expected to be more apparent when
antibodies interact with protein antigens that, due to the
high degree of structural disorder and ﬂexibility deﬁned
in its amino acid sequence, display a high tendency to
engage in promiscuous interactions with other proteins [10,
11]. Some of these features can be identiﬁed in proteins
using a variety of predictive algorithms that help in the
identiﬁcation of structural disorder [12, 13]a n dB - c e l l
epitopes[14].Acomplementaryapproachthatcouldbeused
to identify such sequences is to scan proteins looking for
the absence of structural features known to limit protein
ﬂexibility and that induce, through an eﬀect on protein
folding, the formation of conformational B-cell epitopes.
One such structure, the disulﬁde bridge, is formed when
a protein that has at least 2 cysteine residues is allowed to2 Journal of Biomedicine and Biotechnology
fold under the oxidative conditions prevalent in extracellular
compartments of tissues. It follows that secreted proteins
incapable of forming disulﬁde bridges because of a lack
of cysteine residues represent potential targets of cross-
reactive vaccines directed to linear, nonconformational, and
ﬂexible epitopes. In order to understand both the biological
signiﬁcance that the absence of cysteine residues in pathogen
proteins might have in the immunobiology of ABDs and the
potential of cysteine-free proteins (CFPs) as vaccine targets,
weconductedacysteine-abundanceanddistributionanalysis
on secreted proteins from ten species of arthropod-borne
pathogens that cause serious human pathologies, including
malaria, Lyme disease, plague, tularemia, Q fever, rocky
mountain-spotted fever, human granulocytic anaplasmosis,
human monocytic ehrlichiosis, scrub typhus, and Carrion’s
disease. This analysis allowed for the identiﬁcation of three
major patterns of cysteine expression in secreted proteins
of arthropod-borne pathogens. For comparison purposes, a
similar abundance and distribution analysis was conducted
foranotheraminoacidresidueoflowabundanceinproteins:
tryptophan. The signiﬁcance of the patterns described is
discussed in the context of microbial evolution, host-parasite
relationships, and prospects for the development of vaccines
directed to control several ABDs simultaneously.
2.MaterialsandMethods
2.1. Genomes Analyzed. Ten arthropod-borne pathogens
were selected for cysteine- and tryptophan-distribution
analysis, including ﬁve species of Alphaproteobacteria
(Anaplasma phagocytophilum, Bartonella bacilliformis,
Ehrlichia chaﬀeensis, Orientia tsutsugamushi, and Rickettsia
rickettsii), three Gammaproteobacteria (Coxiella burnetii,
Francisella tularensis, and Yersinia pestis), one Spirochaetes
(Borrelia burgdorferi), and one protozoan parasite
(Plasmodium falciparum). In order to reveal potential
links between the expression of secreted cysteine-free
proteins (sCFPs) and/or secreted tryptophan-free proteins
(sWFPs) with virulence and pathogenicity, the genomes
of two nonpathogenic bacteria harbored by arthropods
(Wigglesworthia glossinidia endosymbiont of Glossina
brevipalpis and Wolbachia endosymbiont of Drosophila
melanogaster) were included in the analysis.
2.2. Bioinformatics Tools and Procedures Used. FTP ﬁles
of the genomes of selected species of arthropod-borne
microorganisms were downloaded from NCBI Reference
Sequences (RefSeq) and transferred to word processing ﬁles
for analysis of cysteine- and tryptophan-abundance and
distributionpatterns.Welimitedtheanalysistoproteinsofat
least 200 amino acid residues in length because cysteine and
tryptophan are low-abundance amino acids (average content
of 1.38% and 1.09%, resp., in UniProtKB/Swiss-prot protein
knowledgebase, release 57.2), and thus the signiﬁcance of
their absence is highly dependent on sequence length.
Incomplete sequences or those with sequence ambiguities
were not included and care was taken to minimize the
degree of redundancy of the list of proteins analyzed by
manually removing exact copies. The selected sequences
were then analyzed using the Simple Modular Architecture
Research Tool (SMART) [15] to detect the presence of
domains and motifs that can be used to assign functionality
and to track evolutionary trends via analysis of orthologs.
SMART has a built-in SignalP 3.0 predictor that was used to
identify proteins secreted through a classical signal-peptide-
dependentpathway[16],whichallowedfortheidentiﬁcation
of a subset of proteins with cysteine or tryptophan residues
conﬁned to the predicted signal peptide segment.
3. Results
3.1. Frequency of CFPs and WFPs in the Genomes of
Arthropod-Borne Microorganisms. W h i l ei ti sp o s s i b l et o
retrieve the sequence of CFPs from the UniProtKB/Swiss-
Prot database with the ExPASy ScanProsite tool using the
 {C}
∗  syntax for pattern recognition, a very important
subset of proteins is overlooked: those that have cysteine
residuesconﬁnedtoanamino-terminalsegmentpredictedto
be excised upon secretion via the signal-peptide-dependent
pathway. The precursor of those proteins would not be
cysteine free but the mature-secreted protein would be
(Figure 1). For that reason, all proteins of at least 200
residues with cysteine residues conﬁned to a 70-amino acid
NH2-terminal segment were analyzed for the presence of
potential signal peptides. Similar attention was taken while
screening for the presence of WFPs. The frequency of CFPs
found in the genome of the 12 species of arthropod-borne
microorganisms studied was found to be as low as 0.94% in
A. phagocytophilum a n da sh i g ha s1 6 . 8 %i nB. burgdorferi.
For WFPs, the lowest percentage (3.86%) was found in C.
burnetii and the highest (16.21%) in B. burgdorferi (Table 1).
When only those proteins predicted to be secreted through
the signal-dependent pathway were considered (sCFPs and
sWFPs), a clear diﬀerence was detected with preferential
secretion of WFPs by four species of Alphaproteobacteria
(A. phagocytophilum, E. chaﬀeensis, O. tsutsugamushi, and R.
rickettsii) and the only eukaryote included in the study, P. fal-
ciparum. In contrast, the other arthropod-borne pathogenic
bacteria (B. bacilliformis, C. burnetii, F. tularensis, Y. pestis,
and B. burgdorferi) preferentially secrete CFPs. Of interest,
the two arthropod endosymbionts included in the study
(W. glossinidia and W. endosymbiont of D. melanogaster)
do not have preference for the secretion for either CFPs
or WFPs (Table 1). When the ratio of sCFPs to sWFPs was
plotted against the percentage of sCFPs, a clear separation
of pathogenic and nonpathogenic microorganisms became
evident in a logarithmic plot (Figure 2). P. falciparum and
four species of pathogenic Alphaproteobacteria segregated
into the lower left corner of the plot while B. bacilliformis, B.
burgdorferi, and the three species of pathogenic Gammapro-
teobacteria segregated to the upper right corner of the plot.
Thetwospeciesofarthropodendosymbiontsremainedatthe
center of the plot.
3.2. CFPs and WFPs in Functionally Deﬁned Proteins
Secreted by Proteobacteria. In order to deﬁne the biologicalJournal of Biomedicine and Biotechnology 3
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>gi|110671084|ref|YP 667641.1| lipoprotein [F. tularensis]
>gi|108811011|ref|YP 646778.1| adhesin system component [Y. pestis]
>gi|121602140|ref|YP 989591.1| surface antigen/outer membrane protein, OMP85 family [B. bacilliformis]
>gi|124805602|ref|XP 001350486.1| blood stage antigen 41–3 precursor [P. falciparum]
Figure 1: Amino acid sequence of proteins secreted by four arthropod-borne pathogens (F. tularensis, Y. pestis, B. bacilliformis, and P.
falciparum) with cysteine residues (shaded in gray) conﬁned to the predicted signal peptide segment (boxed italics) of their precursors.
Signal peptide excision sites were identiﬁed using the SMART online tool. The number of cysteine residues present in the signal peptide
segments shown varies from one in F. tularensis lipoprotein to four in P. falciparum blood stage antigen. The mature proteins produced
following the removal of signal peptide segments during the secretion process are free of cysteine residues.
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Figure 2: Frequency of sCFPs (percentage) plotted against a ratio of sCFP/sWFP in 12 arthropod-borne microorganisms. A logarithmic
scale of the x and y axes was used to improve visual separation of microorganisms with low sCFP/sWFP ratios.
signiﬁcance of the absence of cysteine or tryptophan residues
in proteins secreted by arthropod-borne pathogens, it is
necessary to determine the abundance of such residues in
the corresponding orthologs secreted by other pathogenic
and nonpathogenic microorganisms that are not transmitted
by arthropods. We selected to conduct this analysis in
P r o t e o b a c t e r i ab e c a u s ei ti sal a r g et a x o n o m i cg r o u p
with 466 complete genomes sequenced, including many
species of pathogenic bacteria with well-characterized
virulence and pathogenicity determinants. Furthermore,
the majority of the arthropod-borne microorganisms
included in this study (10 out of 12) belong to the
Proteobacteria phylum. We selected 28 diﬀerent families
of proteins secreted by Proteobacteria and belonging to4 Journal of Biomedicine and Biotechnology
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Figure 3: Abundance and distribution analysis of cysteine (left panel) and tryptophan residues (right panel) in secreted proteins belonging
to 28 diﬀerent families and secreted by many species of pathogenic and non/pathogenic Proteobacteria. The protein families were arranged
by cysteine abundance and distribution to optimize the visualization of patterns.
Table 1:Abundanceofproteinsdevoidofcysteineresidues(CFP)ortryptophanresidues(WFP),includedthosepredictedassecreted(sCFP
and sWFP), in 12 species of arthropod-borne microorganisms.
Species Proteins∗ CFP (%) WFP (%) sCFP sWFP sCFP/sWFP
Alphaproteobacteria
A. phagocytophilum HZ 1264 12 (0.94) 77 (6.09) 7 20 0.35
O. tsutsugamushi str. Boryong 1182 15 (1.26) 71 (6.00) 3 8 0.37
E. chaﬀeensis str. Arkansas 1105 20 (1.80) 133 (12.03) 12 34 0.35
R. rickettsii str. “Sheila Smith” 1345 40 (2.97) 99 (7.36) 14 21 0.66
W. endosymbiont of D. melanogaster 1195 36 (3.01) 90 (7.53) 13 14 0.92
B. bacilliformis KC583 1282 86 (6.70) 74 (5.76) 43 12 3.58
Gammaproteobacteria
W. glossinidia endosymbiont of G. brevipalpis 611 26 (4.25) 71 (11.62) 6 6 1.00
F. tularensis subsp. tularensis FSC198 1605 78 (4.85) 133 (8.28) 54 19 2.84
C. burnetii RSA 493 2016 114 (5.65) 78 (3.86) 63 12 5.25
Y. pestis Nepal 516 3981 339 (8.51) 157 (3.94) 216 32 6.75
Spirochaetes
B. burgdorferi B31 851 140 (16.45) 138 (16.21) 89 36 2.47
Apicomplexa
P. falciparum 3D7 5267 64 (1.21) 567 (10.76) 26 115 0.22
∗Chromosomal proteins only.
diﬀerent functional categories to conduct the cysteine-
and tryptophan-abundance and distribution analysis.
The domains identiﬁed in the proteins selected for this
analysis allowed for access (using a SMART window
to proteins of similar composition) to the sequence of
orthologs present in other species of Proteobacteria. The
number of cysteine and tryptophan residues present in
the mature proteins selected was recorded and a ﬁgure
indicating their relative abundance was visually inspected
for emergence of patterns (Figure 3). When considering the
abundance and distribution of cysteine residues in these
protein families, three diﬀerent patterns were detected.
Pattern-I, which was found in proteins carrying 9 diﬀerent
domains (LolB, MCE, TolB N, VacJ, Flip, Lipoprotein 9,
Lipoprotein 18, CsgG, and GagX), is characterized by
a predominance of CFPs over proteins expressing one
or more cysteine residues. Pattern-II, which was found
in proteins carrying the DsdB, 60KD IMP, or A2M N
domains, shows a predominance of proteins expressing
one cysteine residue and rarely expressing CFPs. Finally,
Pattern-III was found in proteins expressing 16 diﬀerent
sets of domains (Sur A N/Rotamase, Bac surface Ag, PLA1,Journal of Biomedicine and Biotechnology 7
Table 2: Domain and functional groups associated with each cysteine-abundance and distribution-pattern detected in pathogenic and
nonpathogenic Proteobacteria.
Patterns Functional category Domains
Pattern-I Lipoproteins CsgG, Lipoprotein 9, Lipoprotein 18, LolB, VacJ
Part of protein-secretion systems CagX, FliP, MCE, TolB N
Pattern-II Endopeptidase inhibitory activity A2M N
Generation of reduced environment in periplasm DsdB
Protein insertion into membranes 60KD IMP
Pattern-III Adhesin Haemagg act, Pertactin, Autotransporter
Invasin IalB
Hemolysin POTRA 2, ShlB
Enzyme PLA1, Acid phosphatase A, AlkPPc, Glyco hydro 3, Hydrolase 2,
Peptidase S13
Surface antigen Bac surface Ag, BMP, Surface Ag 2
Membrane transporter LamB
LamB, Pertactin/Autotransporter, Bmp, Glyco hydro 3,
Haemagg act, Surface Ag 2, AlkPPc, POTRA 2/ShlB,
Peptidase S13, Acid phosphatases A, Hydrolase 2, DsbC N,
and IalB) and was characterized by a wider variety of
cysteine abundance, but with a clear preference for even
numbers of residues. It is possible that this segregation into
3p a t t e r n si sar e ﬂ e c t i o no faf u n c t i o n a ls p e c t r u md e ﬁ n e d
by structural requirements of reduced sulfhydryl groups
(as in proteins of Pattern-II), correct folding and rigidity
conferred by a deﬁned number of disulﬁde bonds (as in
proteinsofPattern-III),andhighﬂexibilityandpromiscuous
interactivity conferred by the absence of cysteine residues (as
in proteins of Pattern-I). In support of this interpretation,
a correlation was found between functionality and cysteine
abundance and distribution patterns for proteins secreted by
Proteobacteria (Table 2). In contrast to the clear deﬁnition
of cysteine-expression patterns in the proteins analyzed, no
clear patterns emerged when analyzing the abundance and
distribution of tryptophan residues. With the exception of
proteins carrying the Surface Ag 2d o m a i n( w h i c hh a v ea
dominant WFPs proﬁle) and those carrying the DsbC N
and IalB domains (which preferentially express a single
tryptophan residue), no particular pattern of tryptophan
residues was observed, with most proteins expressing a
variable number of tryptophan residues, frequently more
than 10 per protein.
3.3.SecretedCFPsinPathogenicArthropod-BorneProteobacte-
ria. ManysCFPswerefoundin pathogenic arthropod-borne
Proteobacteria, including 79 in Alphaproteobacteria and 333
inGammaproteobacteria(Table 1).Inordertoidentifythose
that could represent virulence and pathogenicity determi-
nants or potential vaccine targets, we eliminated from con-
siderationthosewithdomainsdetectedinsCFPsofanyofthe
arthropod endosymbionts included in the study. Still, a large
list of sCFP-associated domains remained with 42 present
in Alphaproteobacteria (Table 3) and 137 in Gammapro-
teobacteria (Table 4). In addition to these proteins, a group
of sCFPs, characterized by the absence of any of the domains
Table 3: Domains associated with secreted CFPs in four species of
arthropod-borne Alphaproteobacteria.
Species Domains
A. phagocytophilum OEP, Peptidase M16, Peptidase M17,
Peptidase S49, TPR 2
B. bacilliformis ABC sub bind, Ami 3, Autotransporter,
Bac surface Ag,B P Dtransp 1, DPBB 1,
DUF165, DUF374, DUF541, FlgH, Flgl, FliP,
HAMP, HATPase C, HisKA, HlyD,
Lipoprotein 9, LolA, MotA ExbB, OEP,
Oxidored q3, PDZ, Peptidase M23,
Peripla BP 2, Pertactin,P o r i n2, SBP bac 9,
Surf Ag VNR, TolB N, PD40, Trypsin, TSPc
E. chaﬀeensis Bac surface Ag, BON, OEP, PDZ,
Peptidase S49, Surf Ag VNR,T e r C ,T r y p s i n
R. rickettsii AAA, Bac surface Ag, DUF6, FTR1, OmpW,
PBPb, PDZ, Peptidase M23, Surf Ag VNR,
Trypsin, TSPc
Bold font domains selected for deﬁnition of cysteine-abundance and
distribution patterns (Figure 3).
registered in the SMARTand Pfamdatabasesand conformed
by segments of low complexity, intrinsic disorder, coiled-coil
structure, transmembrane regions, and/or internal repeats,
was found among the CFPs secreted by these pathogens.
These sequences were found to be particularly abundant in
Gammaproteobacteria, with 14 present in C. burnetii, 22
in F. tularensis, and 28 in Y. pestis. Only one was found in
both A. phagocytophilum and O. tsutsugamushi, three in R.
rickettsii, four in E. chaﬀeensis, and seven in B. bacilliformis.
One strategy to identify proteins of interest in such a large
list of candidates is to focus on those with the longest
sequence of amino acid residues. After all, the signiﬁcance
of absence of a particular residue in a protein is highly
dependent on protein length. When only the precursors
of at least 500 amino acid residues were considered, few
domains were identiﬁed (Table 5). Of these, the Pertactin
and Autotransporter domains are of interest to understand8 Journal of Biomedicine and Biotechnology
Table 4: Domains associated with secreted CFPs in arthropod-
borne Gammaproteobacteria.
Species Domains
C. burnetii AAL decarboxy, Acid phosphat B,
Bac surface Ag,B a cUbq Cox, BPD transp 1,
Cation eﬄux, DUF2066, DUF502, FKBP N,
FtsQ, FtsX, HlyD, Lipoprotein 9, LolB,L y sM ,
MCE,M o t AExbB, MreC, MVIN,
OmpA membrane, OpuAC, Oxidored q1, PDZ,
Peptidase M16, Peptidase M22, Peptidase M23,
Peptidase M50, Peptidase S24, PNTB,
Polysacc deac 1, POTRA 1, Sec GG, SecD SecF,
S e c Y ,S L T ,S P O R ,Surf Ag VNR, TolB N, PD40,
Toluene X, Trypsin, TSPc
F. tularensis Bac surface Ag, DUF1239, DUF165,
G glu transpept, GDPD, HlyD, LolB,L y sM,
MCE,N e u rchan LBD, OEP, PD40,
Peptidase M50, Peroxidase, PQQ, RmuC,
SBP bac 9, Sec GG, SecD SecF, Secretin, SOUL,
Sugar tr, SurA N, Surf Ag VNR, TolB N, VacJ,
VWA, WZZ
Y. pestis Abhydrolase BP 2, ADC lyase, Ami 2, ArsB,
AsmA, Autotransporter, Bac surface Ag, BON,
BPD transp 1, Cache 1, CsgG,D P B B1,
DUF1284, DUF1454, DUF1471, DUF187,
DUF218, DUF481, DUF541, DUF6, DUF799,
DUF945, Ell-Sor, FKBP N, Flgl, FliP,F M Nbind,
GDPD, Glyco hydro 3, GntP permease,
Haemagg act,H A M P ,H A T P a s eC, HIM, HisKA,
HlyD, KdgM, KdpC, Kelch 2, Lactamase B,
LamB, Lipase GDSL, Lipoprotein 18,
Lipoprotein 9, LolB,L y a s e8, Lyase catalyt,
Lyase N, Lys M, MA, MalM, MgtC, MotA ExbB,
MS channel, OEP, Omptin, OmpW,
Oxidored q1, PAS, Patatin, PbH1, PBP5 C, PBPb,
PD40,P D Z ,P e c t a t elyase 2, Peptidase M16,
Peptidase M23, Peptidase M48, Peptidase S11,
Peripla BP 1, Peripla BP 2, Pertactin,
PG binding 1, Pili assembly N, PLA1,P l u g ,
Polysacc deac 1, Porin 1, PQQ, Rotamase, RpiB,
SBP bac 1, SBP bac 5, SBP bac 7, SBP bac 9,
Secretin, Slp, SLT, SPOR, STAS, Sulfatase,
SurA N, Surf Ag VNR,T Mhelix, Tol tol Ttg2,
TolB N, Toluene X, TonB, TonB dep Rec, TPR 2,
Transgly, Trypsin, TSPc, UPF0118, VacJ,V W A ,
YscJ FliF, ZipA C
Bold font domains selected for deﬁnition of cysteine-abundance and
distribution patterns (Figure 3).
the role of sCFPs in the immunobiology of ABDs because
they have been identiﬁed as virulence and pathogenicity
determinants [17, 18]a n db e c a u s eb o t hh a v eb e e nf o u n d
to be coexpressed in very large sCFPs, including a Y. pestis
protein of 3710 amino acids (GenBank accession number
gi: 45443160). Another domain of interest, Bac surface Ag,
represents a potential target for multipathogen vaccines
directed to sCFPs because it is the only domain found
associated with sCFPs of six species of arthropod-borne
Proteobacteria (Table 5) and in a 821-amino acid residue
outer membrane CFP secreted by B. burgdorferi Spirochetes
(GenBank accession number gi: 15595140).
4. Discussion
Several technical hurdles have complicated the development
of eﬀective vaccines to control the transmission of ABDs,
including (1) identiﬁcation of protective epitopes expressed
on the pathogen and/or its arthropod vector, (2) induction
of safe and long-lasting immunity that overcomes immune
evasion mechanisms used by the pathogens and ampliﬁed by
immuno-modulators present in arthropod saliva [19, 20],
and (3) induction of an immunity expected to operate
eﬀectively in human populations of tremendous diversity.
Some of these problems derive from the assumption
that the induction of species-speciﬁc immunity is the
most eﬀective approach to develop vaccines to prevent
infectious diseases. Research into an alternative approach,
the induction of immunity of broad speciﬁcity, can beneﬁt
from the great diversity of pathogens and vectors involved
in the etiopathogenesis of ABDs in order to identity the
cross-reactive epitopes required for the induction of cross-
protective immunity. Just as adaptation of arthropods to
hematophagyisanexampleofconvergentevolution[21],the
adaptation of microbial pathogens to the complex biological
processes that guarantees their survival and multiplication in
two very diﬀerent kinds of hosts, vertebrate and invertebrate,
c a nb es e e na sa ne x a m p l eo fc o n v e r g e n te v o l u t i o na s
well. Under such consideration, the identiﬁcation of
common structural determinants in molecules secreted by
pathogens into the host-parasite interface might shed light
into vulnerabilities of the host defense systems, providing
opportunities for the design of alternatives to control
ABDs. The availability of complete genomes in many of the
etiologic agents of ABDs oﬀers the possibility to identify,
via the comparative analysis of their secretomes described
herein, such structural determinants.
4.1. Cysteine Residues in Protein Function and Antigenic-
ity/Immunogenicity. One of the amino acid residues with
a prominent eﬀect on the structure of proteins, cysteine,
can be expected to play critical roles in protein function,
antigenicity and immunogenicity. The role played by
cysteine residues in protein function has been demonstrated
in numerous experiments using chemical modiﬁcation
techniques and cysteine scanning mutagenesis [22, 23], but
its role in antigenicity and immunogenicity of proteins is
onlybeginningtobecharacterizedusingthesametechniques
[24]. The ﬂexibility that characterizes a group of proteins
with a clear cysteine use bias, Intrinsically Unstructured
Proteins [10–13], can play a prominent role in host-parasite
relationships by favoring protein-protein interactions
of low aﬃnity and speciﬁcity. From an interactomics
perspective, this kind of protein-protein interactivity might
favor the interaction of pathogen-secreted proteins with
nondefense proteins present in host tissues, thus interfering
with pathogen recognition by defense proteins [25]. As a
result, immunization with these cysteine-depleted proteinsJournal of Biomedicine and Biotechnology 9
Table 5: Domains associated with sCFPs of at least 500 residues in length and present in more than one species of the indicated species of
arthropod-borne Proteobacteria: A. phagocytophilum (A.p), B. bacilliformis (B.b), E. chaﬀeensis (E.c), R. rickettsii (R.r), C. burnetii (C.b), F.
tularensis (F.t), and Y. pestis (Y.p).
Domains A.p B.b E.c R.r C.b F.t Y.p
PBP dimer/Transpeptidase — — — — 1 1 —
Peptidase M16 1 — — — — — 1
Pertactin/Autotransporter — 1 — — — — 3
Sec GG/SecD SecF — — — — 1 1 —
Secretin — — — — — 1 1
Bac surface Ag — 2 1 1 1 1 2
might shift the balance toward protective immunity against
pathogens that secreted them [26].
4.2. Evolutionary Considerations on the Secretion of CFPs
by Proteobacteria. Judged by the contrast between cysteine-
and tryptophan-abundance and distribution expression
patterns identiﬁed in 28 families of proteins secreted by
Proteobacteria, a restrictive evolutionary process must be in
operation to keep some of these proteins in a cysteine-free
state (Figure 3). This is particularly evident in all proteins
classiﬁed in Pattern-I which includes nine families of surface
lipoproteins and components of protein-transport systems.
This expression pattern is better explained by the idea
that these families of proteins were derived from ancestors
that were themselves free of cysteine residues. During
the radiation of species a variable number of mutations
might have occurred that introduced additional tryptophan
residues in the proteins without restriction. While a similar
process might have led to the diversiﬁcation in the number
of cysteine residues, a restrictive force must have kept it
to a minimum. Given that this occurred in all species of
Proteobacteria, including those known to be pathogenic and
nonpathogenic to vertebrates and arthropods, it is unlikely
that the immune systems of these hosts were responsible
for the restriction. Most likely, the function of the proteins
belonging to this group of proteins is seriously compromised
by the introduction of cysteine residues. A somewhat similar
mechanism might have operated during the evolution of
the three families of proteins classiﬁed in Pattern-II. An
ancestor with a single cysteine residue may have evolved
under conditions that allowed the acquisition of cysteine
residues but restricted its loss. The case of proteins carrying
the A2M N domain is peculiar because it is the only
family of proteins where a variable, and odd number, of
cysteine residues predominates. This suggests that while the
accumulation of cysteine residues through the evolution of
this family was fully permitted, those individuals with an
odd number of residues had a survival advantage, probably
because the function of the A2M N domain, just as it is
knowntooccurinvertebrateproteinscarryingit,dependson
the availability of a free sulfhydryl group [27]. One scenario
that could explain the more complex cysteine-abundance
and distribution analysis of the families of proteins classiﬁed
in Pattern-III is that the ancestor of these protein families,
starting with an even number of cysteine residues, evolved
under conditions that allowed either the acquisition or loss
of cysteine residues. Once again the survival advantage of
having, in this case, an even number of cysteine residues
explains the overall pattern. Under this hypothetical scenario
it becomes necessary to explain a peculiar jump in protein
evolution. In the case of protein families carrying the
Bmp, Glyco hydro 3, Haemagg act, Surface Ag 2, AlkPPc,
POTRA 2/ShlB, and Peptidase S13 domains (which would
be predicted to derive from ancestors with two cysteine
residues and thus the potential to have a disulﬁde bond
in the protein structure, Figure 3) could be transformed
into a protein where the formation of disulﬁde bonds is
no longer possible because of the loss of two cysteine
residues. How much protein functionality is aﬀected by the
disappearance of the only disulﬁde bond present in the
structure of these proteins? Similarly one could ask: How
much is the function of a protein devoid of cysteine residues
aﬀected when accumulation of two cysteine residues allows
the emergence of disulﬁde bonds in the protein structure?
This complementary scenario could occur with proteins
carrying the Sur A/Rotamase, Bac surface Ag, PLA1, LamB,
and Pertactin/Autotransporter domains.
5. Conclusions
It is apparent that cysteine residues play a dramatic role in
protein function and that their removal, or introduction,
into protein sequences represents a critical event of great
signiﬁcance in pathogen evolution and host-parasite rela-
tionships. The use of the a simple and novel bioinformatics
tool, amino acid-abundance and distribution analysis, can
prove useful in the clariﬁcation on some of these ideas and
address others that were not included in the discussion,
such as the role of sWFPs in host-parasite relationship, in
particular in the context of two arthropod-borne diseases
that are caused by pathogens that secrete them abundantly,
B. burgdorferi and P. falciparum. The use of cysteine- and/or
tryptophan-directed mutagenesis will prove instrumental in
clarifying the role that these amino acid depleted proteins
may have in the immunobiology of ABDs. It will also open
to experimentation the usefulnessof vaccines based on a new
kind of epitope, one deﬁned not by what it contains in its
sequence, but rather by what it lacks.10 Journal of Biomedicine and Biotechnology
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